Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid

Archives of Dermatological Research

Volumn 307, Issue 4, 2015, Pages 291-298

  Alpsoy, Erkan ^a   Akman Karakas, Ayse ^a   Uzun, Soner ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Autoimmune bullous diseases; Bullous pemphigoid; Epidemiology; Pemphigus

Indexed keywords

ADULT; AGE DISTRIBUTION; ETHNIC GROUP; FEMALE; GEOGRAPHY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PEMPHIGUS;

ADULT; AGE DISTRIBUTION; ETHNIC GROUPS; FEMALE; GEOGRAPHY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PEMPHIGUS;

EID: 84931750184     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1531-1     Document Type: Review

References (70)

1. Aboobaker J, Morar N, Ramdial PK, Hammond MG (2001) Pemphigus in South Africa. Int J Dermatol 40:115–119
2. Adam BA (1992) Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 31:42–45
3. Ahmed AR, Wagner R, Khatri K et al (1991) Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 88:5056–5060
4. Ahmed AR, Yunis EJ, Khatri K et al (1990) Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 87:7658–7662
5. Akman A, Kacaroglu H, Yilmaz E et al (2008) Periodontal status in patients with pemphigus vulgaris. Oral Dis 14:640–643
6. Amin MN, Islam AZ (2006) Clinical, histologic and immunologic features of pemphigus in Bangladesh. Int J Dermatol 45:1317–1318
7. Baican A, Baican C, Chiriac G et al (2010) Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int J Dermatol 49:768–774
8. Bastuji-Garin S, Joly P, Lemordant P et al (2011) Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 131:637–643
9. Bastuji-Garin S, Joly P, Picard-Dahan C et al (1996) Drugs associated with bullous pemphigoid. a case-control study. Arch Dermatol 132:272–276
10. Bastuji-Garin S, Souissi R, Blum L et al (1995) Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 104:302–305
11. Benchikhi H, Ghafour S, Disky A et al (2008) Pemphigus: analysis of 262 cases. Int J Dermatol 47:973–975
12. Bernard P, Vaillant L, Labeille B et al (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131:48–52
13. Bertram F, Bröcker EB, Zillikens D et al (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434–440
14. Bourdon-Lanoy E, Roujeau JC, Joly P et al (2005) Bullous pemphigoid in young patients: a retrospective study of 74 cases. Ann Dermatol Venereol 132:115–122
15. Brenner S, Tur E, Shapiro J (2001) Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 40:562–569
16. Chams-Davatchi C, Valikhani M, Daneshpazhooh M et al (2005) Pemphigus: analysis of 1209 cases. Int J Dermatol 44:470–476
17. Colbert RL, Allen DM, Eastwood D et al (2004) Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 122:1091–1095
18. Cozzani E, Parodi A, Rebora A et al (2001) Gruppo Ligure di Studi in Dermatologia (GLISID). Bullous pemphigoid in Liguria: a 2-year survey. J Eur Acad Dermatol Venereol 15:317–319
19. Culton DA, Qian Y, Li N et al (2008) Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun 31:311–324
20. Daneshpazhooh M, Chams-Davatchi C, Payandemehr P et al (2012) Spectrum of autoimmune bullous diseases in Iran: a 10-year review. Int J Dermatol 51:35–41
21. Delgado JC, Hameed A, Yunis JJ et al (1997) Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol 57:110–119
22. Delgado JC, Turbay D, Yunis EJ et al (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 6(93):8569–8571
23. Delgado JC, Yunis DE, Bozon MV et al (1996) MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens 48:668–672
24. Diaz LA, Glamb RW, Silva J Jr (1980) A syndrome of multiple immune autoreactivity. A breakdown in immune regulation. Arch Dermatol 116:77–79
25. Firooz A, Mazhar A, Ahmed AR (1994) Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol 31(3 Pt 1):434–437
26. Golusin Z, Poljacki M, Jovanovic M et al (2005) Some epidemiological features of pemphigus chronicus in South Vojvodina: a 12-year retrospective study. Int J Dermatol 44:792–793
27. Gudi VS, White MI, Cruickshank N et al (2005) Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol 153:424–427
28. Hahn-Ristic K, Rzany B, Amagai M et al (2002) Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans. J Eur Acad Dermatol Venereol 16:68–71
29. Hietanen J, Salo OP (1982) Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 969 and 1978. Acta Derm Venereol 62:491–496
30. Huang YH, Kuo CF, Chen YH et al (2012) Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: a Nationwide Population-Based Study. J Invest Dermatol 132:92–97
31. Huh WK, Tada J, Fujimoto W et al (2001) Thyroid gland tumour, pemphigus foliaceus and myasthenia gravis in the daughter of a woman with myasthenia gravis. Clin Exp Dermatol 26:504–506
32. Jin P, Shao C, Ye G (1993) Chronic bullous dermatoses in China. Int J Dermatol 32:89–92
33. Joly P, Baricault S, Sparsa A et al (2012) Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 132:1998–2004
34. Jung M, Kippes W, Messer G et al (1999) Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 41:266–268
35. Kaya Koc C, Sallakci N, Akman-Karakaş A et al (2013) HLA class I and class II antigens in the patients with pemphigus in Southern Turkey. Int J Dermatol 52:53–58
36. Krain LS, Terasaki PI, Newcomer VD et al (1973) Increased frequency of HLA-A10 in pemphigus vulgaris. Arch Dermatol 108:803–805
37. Kumar KA (2008) Incidence of pemphigus in Thrissur district, south India. Indian J Dermatol Venereol Leprol 74:349–351
38. Langan SM, Smeeth L, Hubbard R et al (2008) Bullous pemphigoid and pemphigus vulgaris–incidence and mortality in the UK: population based cohort study. BMJ 337:a180
39. Lee JJ, Downham TF (2006) Furosemide-induced bullous pemphigoid. Case report and review of literature. J Drugs Dermatol 5:562–564
40. Leshem YA, Katzenelson V, Yosipovitch G, David M, Mimouni D (2011) Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol 50:827–831
41. Lindelöf B, Islam N, Eklund G et al (1990) Pemphigoid and cancer. Arch Dermatol 126:66–68
42. Lo Schiavo A, Ruocco E, Brancaccio G et al (2013) Bullous pemphigoid: etiology, pathogenesis, and inducing factors: Facts and controversies. Clin Dermatol 31:391–399
43. Mahé A, Flageul B, Cissé I et al (1996) Pemphigus in Mali: a study of 30 cases. Br J Dermatol 134:114–119
44. Marazza G, Pham HC, Schärer L et al (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861–868
45. Meyer N, Misery L (2010) Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 9:A379–A382
46. Micali G, Musumeci ML, Nasca MR (1998) Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily. Int J Dermatol 37:197–200
47. Michailidou EZ, Belazi MA, Markopoulos AK et al (2007) Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients. Int J Dermatol 46:356–361
48. Mimouni D, Bar H, Gdalevich M et al (2008) Pemphigus-analysis of epidemiological factors in 155 patients. J Eur Acad Dermatol Venereol 22:1232–1235
49. Nanda A, Dvorak R, Al-Saeed K et al (2004) Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 43:876–881
50. Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T (2000) Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid. J Dermatol 27:149–156
51. Ong E, Goldacre R, Hoang U et al (2014) Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999–2011. Arch Dermatol Res 306:75–80
52. Park MS, Terasaki PI, Ahmed AR et al (1979) HLA-DRW4 in 91% of pemphigus vulgaris patients. Lancet 2:441–442
53. Pisanti S, Sharav Y, Kaufman E et al (1974) Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 38:382–387
54. Roujeau JC, Lok C, Bastuji-Garin S et al (1998) High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465–469
55. Ruocco V, Ruocco E, Lo Schiavo A et al (2013) Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol 31:374–381
56. Salmanpour R, Shahkar H, Namazi MR et al (2006) Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991–2000). Int J Dermatol 45:103–105
57. Serwin AB, Bokiniec E, Piascik M et al (2007) Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005. Med Sci Monit 13:360–364
58. Simon DG, Krutchkoff D, Kaslow RA et al (1980) Pemphigus in Hartford County, Connecticut, from 1972 to 1977. Arch Dermatol 116:1035–1037
59. Sullivan TP, Elgart GW, Kirsner RS (2002) Pemphigus and smoking. Int J Dermatol 41:528–530
60. Tallab T, Joharji H, Bahamdan K et al (2001) The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol 40:570–572
61. Tsankov N, Vassileva S, Kamarashev J et al (2000) Epidemiology of pemphigus in Sofia, Bulgaria. A 16-year retrospective study (1980–1995). Int J Dermatol 39:104–108
62. Uzun S, Durdu M, Akman A et al (2006) Pemphigus in the mediterranean region of Turkey: a study of 148 cases. Int J Dermatol 45:523–528
63. Vega-Memije ME, Saez de Ocariz-Gutierrez MM, Corte-Franco R et al (2001) Analysis of HLA-DR in Mexican patients with pemphigus. Gac Med Mex 137:535–540
64. Venning VA, Wojnarowska F (1995) Induced bullous pemphigoid. Br J Dermatol 132:831–832
65. V’lckova-Laskoska MT, Laskoski DS, Kamberova S et al (2007) Epidemiology of pemphigus in Macedonia: a 15-year retrospective study (1990–2004). Int J Dermatol 46:253–258
66. Waisbourd-Zinman O, Ben-Amitai D, Cohen AD et al (2008) Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol 58:41–48
67. Wong SN, Chua SH (2002) Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol 147:476–480
68. Zakka LR, Reche P, Ahmed AR (2011) Role of MHC Class II genes in the pathogenesis of pemphigoid. Autoimmun Rev 11:40–47
69. Zaraa I, Kerkeni N, Ishak F et al (2011) Spectrum of autoimmune blistering dermatoses in Tunisia: an 11-year study and a review of the literature. Int J Dermatol 50:939–944
70. Zillikens D, Wever S, Roth A et al (1995) Incidence of autoimmune subepidermal blistering dermatoses in a region in central Germany. Arch Dermatol 131:957–958